Details of the Drug Reposition

General Information of This Drug (ID: DMPX83E)

• Drug Name: STMC-103H (DMPX83E)
• Drug Type: Live biotherapeutic product

Information on Drug Reposition of This Drug

2 Phase 1 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Allergic rhinitis	DIS3U9HN	CA08.0	Phase 1	[1]
Atopic dermatitis	DISTCP41	EA80	Phase 1	[1]

References

• [1] Clinical pipeline report, company report or official report of Siolta Therapeutics.